Jove
Visualize
Contact Us

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

132
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
132
Intellectual Disability01:29

Intellectual Disability

60
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
60
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

126
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
126
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

503
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
503
Dementia01:30

Dementia

121
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
121
Language and Cognition01:27

Language and Cognition

357
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
357

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

Neurology·2026
Same author

Magnetic resonance spectroscopy in hospitalised older people shows age and delirium-specific metabolic changes.

Age and ageing·2026
Same author

Dementia diagnosis rates and the impact of ethnicity, rurality and deprivation.

Aging & mental health·2024
Same author

Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK.

The British journal of psychiatry : the journal of mental science·2024
Same author

Differences in care between younger and older patients in the 2019 English national memory service audit.

BJPsych bulletin·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 14, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Mild cognitive impairment: not much harm; not much help.

Jeremy D Isaacs1

  • 1St George's, University of London, UK.

Bjpsych Open
|October 10, 2023
PubMed
Summary

Diagnosing mild cognitive impairment (MCI) has limited benefits and psychosocial impact. Most patients and families don't recall or understand dementia risk implications, with few making lifestyle changes.

Keywords:
Dementias and neurodegenerative diseasesbiomarkersmemory servicesmild cognitive impairmentpatients

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.4K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.0K

Related Experiment Videos

Last Updated: Jul 14, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.4K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.0K

Area of Science:

  • Neurology
  • Gerontology
  • Psychology

Background:

  • Mild cognitive impairment (MCI) is an intermediate state between cognitive health and dementia.
  • Current diagnostic and prognostic methods for MCI, including biomarkers, are imprecise.
  • Effective interventions to prevent dementia progression from MCI are lacking.

Purpose of the Study:

  • To investigate the psychosocial consequences of a mild cognitive impairment diagnosis.
  • To evaluate patient and family recall and understanding of MCI implications.
  • To assess the impact of MCI diagnosis on lifestyle changes and dementia prevention.

Main Methods:

  • The study by Munawar and colleagues examined patients diagnosed with MCI.
  • Data collection likely involved patient and family interviews or surveys.
  • Assessment focused on recall of diagnosis, understanding of dementia risk, and subsequent actions.

Main Results:

  • Most patients and families had poor recall or understanding of the implications of an MCI diagnosis.
  • Only 20% of patients reported making lifestyle changes after diagnosis.
  • The uptake of interventions like hearing aids was notably low.

Conclusions:

  • The clinical diagnosis of MCI has limited effectiveness in promoting 'brain health' or dementia prevention.
  • Psychosocial outcomes suggest cautious optimism, with minimal harm but also limited benefit.
  • Population-level initiatives may be more effective for dementia prevention than clinic-based diagnoses.